FARS2 dificiency; new cases, review of clinical, biochemical, and molecular spectra, and variants interpretation based on structural, functional, and evolutionary significance
Mol Genet Metab 125:281-291, Almannai, M.,et al, 2018
Risk Factors for Spinal Cord Lesions in Dystonic Cerebral Palsy and Generalised Dystonia
JNNP 83:159-163, Guettard,E.,et al, 2012
Congenital Lymphocytic Choriomeningitis Virus Infection: Spectrum of Disease
Ann Neurol 62:347-355, Bonthius,D.J.,et al, 2007
Dopamine-Responsive Dystonia
eMedicine (Apr), Nikhar,N.K., 2006
Consequences of the Delayed Diagnosis of Ataxia-Telangiectasia
Pediatrics 102:98-100, Cabana,M.D.,et al, 1998
Dopa-Responsive Dystonia, Some Pieces of the Puzzle are Still Missing
Neurol 50:853-855, Nygaard,T.G.&Wooten,G.F., 1998
Discontinuation of Antiepileptic Drug Treatment after Two Seizure-Free Yrs in Children with Cerebral Palsy
Pediatr 97:192-197, Delgado,M.R.,et al, 1996
Arginase Deficiency Presenting as Cerebral Palsy
Pediatrics 91:995-996, Scheuerle,A.E.,et al, 1993
Prenatal Origin of Hemiparetic Cerebral Palsy:How Often and Why?
Pediatrics 88:1059-1062, Nelson,K.B., 1991
Dopa Responsive Dystonia:A Treatable Condition Misdiagnosed as Cerebral Palsy
BMJ 298:1019-1020, Boyd,K.&Patterson,V., 1989
Cerebral Palsy Diplegia:Improvements for Walking
BMJ 299:1115-1116, Patrick,J., 1989
Neurodevelopmental Outcome in Babies Weighing Less than 2001 g at Birth
BMJ 294:1582-1586, Marlow,M.,et al, 1987
The Child Who is Slow to Talk
BMJ 285:671-672, Robinson,R.J., 1982
Prognostic Indicators in Hemiparetic Cerebral Palsy
Ann Neurol 9:353-357, Cohen,M.E.,et al, 1981